Identifying likely responders to treatments for Alcohol Use Disorder
Likely responder analysis and tests of model misspecification in randomized controlled trials of treatments for Alcohol Use Disorder
This study is looking for ways to find out which people with Alcohol Use Disorder are most likely to benefit from treatment, so they can get the best help possible.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10869960 on NIH RePORTER |
What this research studies
This research investigates how to better identify individuals who are likely to respond positively to treatments for Alcohol Use Disorder (AUD). By using a statistical model, the study aims to pinpoint these 'likely responders' at the end of clinical trials, allowing for a more tailored approach to treatment. The methodology includes a novel diagnostic tool to ensure the accuracy of the model used to predict treatment responses. This approach seeks to enhance the effectiveness of treatments by focusing on those who will benefit the most.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alcohol Use Disorder who are seeking treatment.
Not a fit: Patients who do not have Alcohol Use Disorder or those who are not seeking treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for individuals with Alcohol Use Disorder.
How similar studies have performed: Previous research has shown promise in using similar statistical approaches to enhance treatment outcomes in clinical trials.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Laska, Eugene M — New York University School of Medicine
- Study coordinator: Laska, Eugene M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.